Heart drugs turn cancer cells into anticancer vaccines

Share this article:

Plant-based drugs primarily used in the treatment of heart failure and arrhythmias have now been found to exert anticancer effects by helping to destroy tumor cells and converting them into a vaccine against remaining cancer cells.

The agents, cardiac glycosides, appear to be exceptionally efficient at inducing “pre-mortem” stress responses in cancer cells, making the cells more vulnerable to the effects of chemotherapy. Moreover, once those cells succumb to treatment, they become vaccines that keep residual tumor cells under control.

As investigators Laurie Menger of Institut Gustave Roussy in Villejuif, France, and colleagues explained in their report in Science Translational Medicine (2012;4[143]:143ra99), some successful chemotherapeutics, particularly anthracyclines and oxaliplatin, induce a type of cell stress and cell death that is immunogenic. The process involved converts the dying cancer cells into a vaccine that stimulates antitumor immune responses.

Menger's group noted that retrospective clinical analysis revealed the heart drug digoxin, a cardiac glycoside, to have a positive impact on overall survival in persons with breast, colorectal, head and neck, or liver cancer when administered during chemotherapy. In the current study, the investigators used fluorescence microscopy to identify cardiac glycosides as effective triggers of immunogenic cell death, and to demonstrate how a combination of chemotherapy plus cardiac glycosides could vaccinate mice against living cancer cells.

The researchers plan to test cardiac glycosides in patients with head and neck cancer.

Share this article:
You must be a registered member of ONA to post a comment.

Next Article in Web Exclusives

Sign Up for Free e-newsletters

What is this?

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Survival equivalent with cetuximab or bevacizumab in metastatic colorectal cancer

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.

Some aggressive cancers may respond to anti-inflammatory drugs

New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs currently used to treat rheumatoid arthritis.

Pain and itch may indicate skin cancer

Pain and itch may indicate skin cancer

Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study.